FDA Drug recall D-0868-2023
G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherr…
- FDA Drug
- Class I
- terminated
- Published 2023-06-07
On 2023-06-07 the FDA classified a Class I recall of G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherr… by Novis Pr, citing product mix-up: incorrect product was found inside the G-Supress DX product carton.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0868-2023 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2023-04-20 |
| Published | 2023-06-07 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Novis Pr |
| Distribution | PR |
Product
G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherry Flavor Sugar & Alcohol Free, packaged in a bottle Net Content: 30 mL (1 oz.) further packaged in a carton, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-655-01
Reason
Product mix-up: incorrect product was found inside the G-Supress DX product carton.
Identifiers
| ndc | 52083-655-01 |
|---|---|
| code_info | Lot: D20911, Exp. Oct/25 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0868-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.